Association of Cytomegalovirus (CMV) DNAemia With Long-Term Mortality in a Randomized Trial of Preemptive Therapy and Antiviral Prophylaxis for Prevention of CMV Disease in High-Risk Donor Seropositive, Recipient Seronegative Liver Transplant Recipients.

导出 OA

翻译打印收藏纠错

作者： Lakshin,Kumar ^[1] ; Sayan,Dasgupta ^[2] ; Cristina,Murray-Krezan ^[3] ; Nina,Singh ^[4] ; Robert M,Rakita ^[1] ; Cynthia E,Fisher ^[1] ; Ajit P,Limaye ^[1]

作者单位： Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington, USA. ^[1] Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. ^[2] Division of General Internal Medicine, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA. ^[3] Department of Medicine, VA Pittsburgh Healthcare System and University of Pittsburgh, Pittsburgh, Pennsylvania, USA. ^[4]

关键词 antiviral therapy cytomegalovirus immunocompromised host liver transplant viral infections

主题词人类(Humans);抗病毒药(Antiviral Agents);巨细胞病毒(Cytomegalovirus);巨细胞病毒感染(Cytomegalovirus Infections);肝移植(Liver Transplantation);组织供者(Tissue Donors);随机对照试验(主题)(Randomized Controlled Trials as Topic)

DOI 10.1093/cid/ciad643

PMID 37862162

发布时间 2024-11-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交